This is the first edition of guidance on infection prevention and control (IPC) strategies for use when infection with a novel coronavirus (2019-nCoV) is suspected. It has been adapted from WHO’s Infection prevention and control during health care for probable or confirmed cases of Middle East respirat...
WHO has developed this interim guidance to meet the need
for recommendations on safe home care for patients with
suspected COVID-19 who present with mild symptoms
a
and
on public health measures related to the management of their
contacts.
This document was adapted from the interim guidance on
Middle Eas...
This document is intended for clinicians taking care of hospitalised adult and paediatric patients with severe acute respiratory infection (SARI) when a nCoV infection is suspected. It is not meant to replace clinical judgment or specialist consultation but rather to strengthen clinical management of the...
Lindner, Andreas K;
Lejon, Veerle;
Chappuis, François;
Seixas, Jorge;
Kazumba, Leon;
Barrett, Michael P;
Mwamba, Erick;
Erphas, Olema;
Akl, Elie A;
Villanueva, Gemma;
Bergman, Hanna;
Simarro, Pere;
Ebeja, Augustin Kadima;
Priotto, Gerardo;
Franco, Jose Ramon.
Human African trypanosomiasis caused by Trypanosoma brucei gambiense is a parasitic infection that usually progresses to coma and death unless treated. WHO has updated its guidelines for the treatment of this infection on the basis of independent literature reviews and using the Grading of Recommendation...
Trypanosomiasis, African/drug therapy,
Trypanosoma brucei gambiense,
Pentamidine/administration & dosage,
Nifurtimox/administration & dosage,
Nitroimidazoles/administration & dosage,
Cerebrospinal Fluid/parasitology,
Drug Therapy, Combination,
Trypanocidal Agents/administration & dosage,
Eflornithine/administration & dosage,
Trypanosomiasis, African/parasitology
A paucity of scientific evidence exists on how to best treat pregnant or breastfeeding women with suspected or confirmed Ebola virus disease (EVD). Historical reports suggest that, among women who acquire EVD during pregnancy, there is increased mortality and morbidity, and a near 100% rate of adverse pr...
Breast Feeding,
Hemorrhagic Fever, Ebola/prevention & control,
Hemorrhagic Fever, Ebola/transmission,
Maternal and Child Health,
Milk, Human/virology,
Ebola Vaccines/therapeutic use,
Pregnancy Complications, Infectious
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of a rapidly spreading illness, Coronavirus Disease 2019 (COVID-19), afecting thousands of people around the world. This guideline provides recommendations to support hospital clinicians managing critically ill adults wit...
This guideline aims to provide specific, patient-focused recommendations on management and care of people with suspected or confirmed COVID-19. With the exception of chemoprophylaxis for the prevention of infection in people exposed to COVID-19, the guideline does not include other interventions used in ...
Clinical Diagnosis/diagnosis,
Betacoronavirus/drug effects,
Coronavirus Infections/diagnosis,
Pneumonia, Viral/diagnosis,
Hypoxia/diagnosis,
Patient Acuity,
Coronavirus Infections/drug therapy,
Pneumonia, Viral/drug therapy,
Dexamethasone/therapeutic use,
Breast Feeding,
Antiviral Agents/therapeutic use,
Hydroxychloroquine/therapeutic use,
Colchicine/therapeutic use,
Plasma/immunology,
Darunavir/therapeutic use,
Interferons/therapeutic use,
Evidence-Based Practice/methods
La finalidad de esta guía es establecer un referente nacional para orientar la toma de decisiones clínicas basadas en recomendaciones sustentadas en la mejor evidencia disponible. Esta guía pone a disposición del personal del primer, segundo y tercer nivel de atención las recomendaciones basadas en ...
La finalidad de esta guía es establecer un referente nacional para orientar la toma de decisiones clínicas basadas en recomendaciones sustentadas en la mejor evidencia disponible. Esta guía pone a disposición del personal del primer, segundo y tercer niveles de atención las recomendaciones basadas e...
WHO published interim guidelines on the prevention of sexual transmission of Zika virus in September 2016, based on a limited amount of evidence under an emergency process during a public health emergency of international concern (PHEIC). The body of evidence has grown considerably since then, and WHO ex...